Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Phi (PHIL) Cash & Equivalents (2016 - 2025)

Phi (PHIL) has disclosed Cash & Equivalents for 15 consecutive years, with $77.0 as the latest value for Q1 2025.

  • On a quarterly basis, Cash & Equivalents fell 99.82% to $77.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $77.0, a 99.82% decrease, with the full-year FY2024 number at $303.0, down 98.47% from a year prior.
  • Cash & Equivalents was $77.0 for Q1 2025 at Phi, down from $310.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $188734.0 in Q3 2021 to a low of $13.0 in Q3 2024.
  • A 5-year average of $41501.5 and a median of $23592.0 in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 67.11% in 2023, then crashed 99.82% in 2025.
  • Phi's Cash & Equivalents stood at $53737.0 in 2021, then plummeted by 64.55% to $19051.0 in 2022, then skyrocketed by 54.54% to $29442.0 in 2023, then tumbled by 98.95% to $310.0 in 2024, then plummeted by 75.16% to $77.0 in 2025.
  • Per Business Quant, the three most recent readings for PHIL's Cash & Equivalents are $77.0 (Q1 2025), $310.0 (Q4 2024), and $13.0 (Q3 2024).